Neothetics, Inc. (NASDAQ:NEOT) Issues Quarterly Earnings Results, Hits Expectations
Neothetics, Inc. (NASDAQ:NEOT) released its quarterly earnings results on Thursday. The biotechnology company reported ($0.20) earnings per share for the quarter, meeting the consensus estimate of ($0.20), Bloomberg Earnings reports.
Neothetics (NASDAQ NEOT) traded up 0.80% during mid-day trading on Friday, reaching $0.38. 329,331 shares of the company traded hands. The company’s 50 day moving average price is $0.62 and its 200 day moving average price is $1.51. The firm’s market capitalization is $5.26 million. Neothetics has a 12-month low of $0.30 and a 12-month high of $2.63.
Separately, ValuEngine cut shares of Neothetics from a “sell” rating to a “strong sell” rating in a report on Tuesday, June 27th.
Neothetics Company Profile
Neothetics, Inc is a clinical-stage specialty pharmaceutical company, which develops therapeutics. The Company focuses on localized fat reduction and body contouring. It focuses on the development of LIPO-202 for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.
Receive News & Ratings for Neothetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neothetics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.